Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.Patrick M. Kochanek, John M. Hallenbeck|Stroke|1992Cited by 620
Immunologic Privilege in the Central Nervous System and the Blood–Brain BarrierLeslie L. Muldoon, Edward A. Neuwelt, Gregory J. del Zoppo et al.|Journal of Cerebral Blood Flow & Metabolism|2012Cited by 307
Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemiaKyra J. Becker, John M. Hallenbeck, Richard M. McCarron et al.|Proceedings of the National Academy of Sciences|1997Cited by 156
Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programmingJoshua D. Bernstock, John M. Hallenbeck|Scientific Reports|2017Cited by 41